Advanced imaging volumes help Lumexa Imaging return to profitability
Lumexa Imaging returned to profitability in the third quarter of 2026 as the outpatient imaging provider reported higher revenue, growth in advanced imaging volumes and an improved earnings outlook for the full year.
The news comes as the company has continued expanding its network and increasing its system-wide sales. In a Nov. 10 announcement, the Raleigh, North Carolina-based company—previously known as US Radiology Specialists—shared that revenue reached $271.97 million for the quarter, which exceeds analysts’ prior estimates of $269.89 million. System-wide sales increased 7.7% year over year, reflecting the company’s continued growth in diagnostic imaging services.
CEO Caitlin Zulla credited record levels of advanced imaging modality utilization and progress among newly opened centers for the growth. The company plans to open three additional locations before the end of the year, with a goal of adding eight to 10 centers in total.
“In Q3, we advanced our business in several meaningful ways while executing against our strategy. Advanced modalities reached a record high as a percent of our volumes, and our newer de novo cohorts continue to ramp on plan,” Zulla said in an earnings announcement. “These achievements mark progress toward our long-term growth plans, and that progress is translating into strong, durable cash generation. We enter the fourth quarter confident in our ability to deliver for patients, partners, and shareholders.”
The company’s net income for the third quarter of 2026 totaled $7.2 million, compared with a net loss of $3.5 million in the third quarter of 2025. Adjusted EBITDA increased to $62.6 million from $59.1 million, while the adjusted EBITDA margin improved to 23%, compared with 22.8% a year earlier.
Advanced outpatient imaging volumes increased 7.9% on a consolidated basis and 8.1% system-wide. Same-center advanced outpatient volumes grew 6.6% and 6.8%, respectively. Advanced procedures accounted for 31.8% of consolidated volume and 38.2% of system-wide volume, increases of 127 and 145 basis points.
The company also raised its full-year adjusted earnings-per-share guidance to $0.86 to $0.90, up from its previous range of $0.71 to $0.77. Lumexa attributed the increase to a lower assumed effective tax rate.
With approximately 190 outpatient imaging centers and more than 5,000 team members, Lumexa conducted about 4 million outpatient procedures system-wide in 2025.
For more detailed information from the earning call, click here.
In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.